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Dapproval. Thoracoscopic treatment of the LAA has been
suggested as a sole therapy for patients with AF to minimize
stroke risk.8 There is evidence to suggest that the AtriClip
device results in electrical isolation, and the device
has been used as an isolated therapy for focal atrial
tachycardia.21
Although the device studied is third generation, the
deployment tool was a first-generation instrument. This re-
usable large deployment tool was cumbersome and can be
used only via a sternotomy. There are 2 currently approved
deployment tools. One is designed for open sternotomy, and
the other is used for thoracoscopic approach. Both are
smaller and more flexible, and have a lower profile than
the deployment tool used in this report.
Limitations
This study is limited in the short-term imaging follow-up
of only 3 months, although clinical follow-up extends to 12
months. This is a relatively small cohort of patients. Longer
follow-up is needed to evaluate for evidence of device mi-
gration. This study was not designed to assess reduction
in stroke risk. Late neurologic events developed in 2 pa-
tients, which did not appear to be related to the LAA to
the best of our knowledge. A significantly larger random-
ized study would be required with longer-term follow-up
to document any efficacy in stroke prophylaxis.
CONCLUSIONS
This multicenter initial trial suggests that exclusion of the
LAA can be performed safely and without injury to the
heart or surrounding structures during open cardiac surgery
with the AtriClip device. In short-term follow-up, there is
evidence of persistent LAA closure with no communication
to the appendage. Long-term studies should be performed to
evaluate the efficacy in the prevention of stroke and rule out
the potential for device migration.
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Dr Bryan Meyers (St Louis, Mo). There was a long list of in-
clusion and exclusion criteria. How restrictive was this trial and
how representative is this patient population compared with the
group of patients you encounter every day in your cardiac surgery
practice?
Dr Ailawadi. On the basis of the exclusion criteria from this
study, I would say approximately half of the patients I see in daily
practice could have qualified for this. The most liberal of the inclu-
sion criteria was age greater than 65 years and hypertension. So
many of the patients we treat meet that criteria in this trial.
Dr Wiley Nifong (Greenville, NC). Great study, great results.
We have been very happy using the clip clinically as well. I didgery c November 2011
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Dnotice early in the learning curve it looked like there were 3 mis-
fires. Of course, while you are using it, you can get it down seated
well. It appears, in the beating heart, to guide itself down. After it
fires, I assume you could just use a wire cutter? You could remove
it if you placed it and noticed it was not seated correctly, is that
correct?
Dr Ailawadi. There are a couple of points to mention about de-
ploying the device. The deployment device we used in this study
was a large metal reusable tool, with a manual release. Once you
release it, it is difficult, but it can be removed. You do not need
a wire cutter, but you essentially take 2 pick-ups, separate the
clip, and pull it off and then reattach it to the deployment tool
and put it on again. The current FDA-approved device has a mech-
anism to open and close, and once you are happy with positioning,
then you go ahead and cut the 4 sutures. So the current deployment
device allows repositioning until it is in optimal position.
Dr Azhar Hossain (Indianapolis, Ind). How do you determine
that you have been successful in excluding the entire appendage?
As you know, there is residual appendage left, and the risk of
thrombosis is still present. So are you using TEE assistance during
the procedure?The Journal of Thoracic and CarDr Ailawadi. It certainly can be done. I can tell you that during
a sternotomy when you have the heart lifted up, it can be challeng-
ing to visualize by TEE. So in this situation, clip placement is by
visual inspection. We do use TEE routinely in all of our cases. I
have also performed this multiple times via a minimally invasive
approach when performing a hybrid AF procedure or thoraco-
scopic AF procedure. In this situation, the heart is in its native po-
sition, and we can visualize by TEE before we deploy the clip.
Dr Bryan Meyers (St Louis, Mo). So you showed efficacy
in the ability to exclude the appendage. The next step is going
to be to show clinical effectiveness, and you are going to need
a huge trial, aren’t you, for the rare events you are trying to
prevent?
Dr Ailawadi. Correct.
Dr Meyers. Any idea of where that is going next?
Dr Ailawadi. This is the million dollar question. I suspect it
will require a large trial of at least 2000 patients. We will need to
see what type of funding is available for this type of study. Ul-
timately, this will be required, not just with this particular device
but with all the devices to see the clinical effectiveness of stroke
reduction.diovascular Surgery c Volume 142, Number 5 1009
